| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2026―Jul―16 |
Systematic review of amino acid profiles among COVID-19 patients caused by SARS-CoV-2 |
Saber Soltani, Hamid Choobineh, Fariba Nabatchian, Mohammad Kord, Bahram Nikmanesh, Farideh Razi, Houran Firouzian, Ziba Majidi |
| 2 |
[GO] |
2026―Jul―08 |
Association between SARS-CoV-2 and diabetes: A population-based cohort study using the UK CPRD GOLD database |
P. Spivakovsky, N. L. Barclay, E. Burn, W. Y. Man, A. Delmestri, A. M. Jödicke, Daniel Prieto-Alhambra, M. Català |
| 3 |
[GO] |
2025―Dez―18 |
Letter to the editor: Comment on “safety and effectiveness of remdesivir in COVID-19 patients with liver dysfunction: a retrospective cohort study” |
Munazza Laique, Mahrukh Imran, Umm e Aiman |
| 4 |
[GO] |
2025―Okt―25 |
Body composition measurement and diabetes - A new perspective on development of antibodies after SARS-CoV-2 booster vaccination |
Lukas Van Baal, Susanne Tan, Dagmar Fuhrer, Johanna Reinold, Ulf Dittmer, Melanie Fiedler |
| 5 |
[GO] |
2025―Okt―23 |
Comment on “Pre-pandemic diabetes and risk of long COVID: Longitudinal evidence” |
Ali Madad Haq |
| 6 |
[GO] |
2025―Okt―23 |
Safety and effectiveness of remdesivir in COVID-19 patients with liver dysfunction: a retrospective cohort study |
Amirmohammad Sharafi, Fatemeh Alsadat Mirzadeh, Abolfazl Zendehdel, shnoo Bayazidi |
| 7 |
[GO] |
2025―Sep―19 |
Pre-pandemic diabetes and risk of long COVID: longitudinal evidence |
Yusuff Adebayo Adebisi, Anas Ali Alhur, Najim Z. Alshahrani, Victor C. Cañezo, Edgar G. Cue, Don Eliseo Lucero-Prisno |
| 8 |
[GO] |
2025―Sep―01 |
The impact of diabetes and obesity on the severity and mortality of SARS-CoV-2 infection |
Tomasz Klaudel, Michał Pelczarski, Monika Zaborska, Jakub Sadowski, Samanta Anna Ostrowska, Adam Drzymała, Rafał Jakub Bułdak |
| 9 |
[GO] |
2025―Mrz―23 |
Predicting COVID-19 progression in hospitalized patients in Kurdistan Province using a multi-state model |
Shnoo Bayazidi, Ghobad Moradi, Safdar Masoumi, Seyed Amin Setarehdan, Hamid Reza Baradaran |
| 10 |
[GO] |
2025―Mrz―03 |
Investigating the association between major dietary patterns and disease outcomes in diabetic and non-diabetic patients with COVID-19: a cross-sectional study |
Atefeh Amrollahi, Zahra Hariri, Tahereh sabaghian, Saeid Kalbasi, Omid nikpayam, Golbon Sohrab |
| 11 |
[GO] |
2024―Jun―12 |
The impact of osteosarcopenia and its parameters on mortality of COVID-19 in-hospitalized older patients: the findings of BEH (Bushehr elderly health) program |
Gita Shafiee, Maryam Marzban, Faeze Abbaspour, Amirhossein Darabi, Narges Zargar Balajam, Akram Farhadi, Mohammad Mehdi Khaleghi, Hossein Taherzadeh, Noushin Fahimfar, Azar Falahatzadeh, Negin Ghasemi, Afshin Ostovar, Iraj Nabipour, Bagher Larijani, Ramin Heshmat |
| 12 |
[GO] |
2024―Feb―14 |
COVID-19-related fear and anxiety in a sample of patients with type 2 diabetes: a cross-sectional study in Iran after several peaks of the pandemic |
Shima Abbasihormozi, Azin Shirin, Roya Hosseini, Mahsa Moayedi, Ahmad Vosough Taghi Dizaj, Marjan Afghan, Azam Kouhkan, Samira Vesali |
| 13 |
[GO] |
2024―Jan―20 |
The prognostic significance of insulin resistance in COVID-19: a review |
Esmaeil Mehraeen, Faeze Abbaspour, Maciej Banach, SeyedAhmad SeyedAlinaghi, Ameneh Zarebidoki, Seyed Saeed Tamehri Zadeh |
| 14 |
[GO] |
2024―Jan―05 |
Obese-friends club: a gamified virtual quasi-experiment for obesity control in adolescents during the COVID-19 pandemic |
Ata Pourabbasi, Amin Akbari Ahangar, Sarah Nouriyengejeh |
| 15 |
[GO] |
2023―Okt―25 |
Comparison of BMI and HbA1c changes before and during the COVID-19 pandemic in type 1 diabetes: a longitudinal population-based study |
Marie Auzanneau, Dorothee M. Kieninger, Katharina Laubner, Christian Renner, Joaquina Mirza, Gerhard Däublin, Kirsten Praedicow, Holger Haberland, Claudia Steigleder-Schweiger, Bettina Gohlke, Angela Galler, Reinhard W. Holl |
| 16 |
[GO] |
2023―Sep―21 |
Understanding impacts of COVID-19 restrictions on glycemic control for patients with diabetes in Japan |
Kiyoko Uno-Eder, Noriko Satoh-Asahara, Manabu Hibiya, Kenji Uno, Takuya Uchino, Koji Morita, Toshio Ishikawa, Tetsuji Kaneko, Hajime Yamakage, Yuki Kitaoka, Tomohiro Sawa, Kazuhisa Tsukamoto, Tamio Teramoto |
| 17 |
[GO] |
2023―Jul―10 |
Correction to: Drug repurposing using computational methods to identify therapeutic options for COVID-19 |
Soodeh Mahdian, Azadeh Ebrahim-Habibi, Mahboobeh Zarrabi |
| 18 |
[GO] |
2023―Mai―22 |
Type 1 diabetes patient experiences and management practices during the COVID-19 pandemic in rural Uganda |
Wenceslaus Sseguya, Steven James, Manfred Bwambale, Emma L Klatman, Graham D Ogle, Mary Munyagwa, Jayanthi Maniam, Ronald Wesonga, Silver Bahendeka |
| 19 |
[GO] |
2023―Mai―15 |
Prediction of in-hospital mortality rate in COVID-19 patients with diabetes mellitus using machine learning methods |
Pooneh Khodabakhsh, Ali Asadnia, Alieyeh Sarabandi Moghaddam, Maryam Khademi, Majid Shakiba, Ali Maher, Elham Salehian |
| 20 |
[GO] |
2023―Apr―20 |
Changes in glycemic control and body weight over the course of the COVID 19 pandemic in an outpatient setting |
Keerthana Haridas, Deborah Edelman |
| 21 |
[GO] |
2023―Apr―08 |
Risks associated with acute pancreatitis (AP) with diabetic ketoacidosis (DKA) in COVID-19 patients: a literature review |
Sundru Manjulata Devi, Annapurna Pamreddy, Venkata Ramana Narendra |
| 22 |
[GO] |
2022―Nov―05 |
COVID-19 anti-vaccine attitude and hesitancy |
Mandana Hasanzad, Hamidreza Namazi, Bagher Larijani |
| 23 |
[GO] |
2022―Okt―15 |
Post COVID-19 neuropsychiatric complications and therapeutic role for TNF-α inhibitors: a case series study |
Gita Shafiee, Tohid Arastou, Ramin Heshmat, Ahmad Reza Jamshidi, Bagher Larijani, Seyed Masoud Arzaghi |
| 24 |
[GO] |
2022―Sep―14 |
Letter to the editor about the article entitled “Proportion and mortality of Iranian diabetes mellitus, chronic kidney disease, hypertension and cardiovascular disease patients with COVID-19: a meta-analysis” |
Ehsan Shahrestanaki, Hadith Rastad |
| 25 |
[GO] |
2022―Jul―24 |
SARS-CoV-2 infection may enhance the adverse effect of thyroid disturbance on climacteric symptoms |
Marzieh Saei Ghare Naz, Fahimeh Ramezani Tehrani |
| 26 |
[GO] |
2022―Jul―22 |
Appraisal of SARS-CoV-2 mutations and their impact on vaccination efficacy: an overview |
Nastaran Hadizadeh, Mousa Naderi, Jafar Khezri, Meysam Yazdani, Mehdi Shamsara, Ehsan Hashemi |
| 27 |
[GO] |
2022―Jul―18 |
Risk factors and outcomes associated with diabetes mellitus in COVID-19 patients: a meta-analytic synthesis of observational studies |
Upasna Gaba, Mohammad Altamish, Md Azharuddin, Mohammad Adil, Pinaki Ghosh, Bishal Gyawali, Yogesh Yadav, Manju Sharma |
| 28 |
[GO] |
2022―Jul―07 |
Risk factors predicting hospital length of stay in older patients with type 2 diabetes with Covid-19 |
Bilal Katipoglu, Mehmet Ilkin Naharci, Eray Serdar Yurdakul |
| 29 |
[GO] |
2022―Jul―06 |
The beneficial role of Hepcidin peptide inhibitor in improved the symptoms of COVID-19 in diabetics: anti-inflammatory and potential therapeutic effects |
Motahareh Zeinivand, Nida jamali-Raeufy, Fahime Zavvari |
| 30 |
[GO] |
2022―Mai―26 |
SELF-CARE AND QUALITY OF LIFE PEOPLE WITH TYPE 2 DIABETES DURING THE COVID-19: CROSS-SECTIONAL STUDY |
Hema Malini, Sonia Zhahara, Devia Putri Lenggogeni, Zifriyanthi Miranda Putri |
| 31 |
[GO] |
2022―Mai―12 |
Impact of the COVID-19 pandemic on visual outcomes of diabetic macular edema patients at a tertiary care veterans affairs center |
Philip Zhou, Jie Gao, Xiaofan Huang, Kristen A. Staggers, Kristin Biggerstaff, Silvia Orengo-Nania, Roomasa Channa |
| 32 |
[GO] |
2022―Apr―06 |
Relationship between depression and psychological well-being among persons with diabetes during COVID-19 pandemic: diabetes distress as a mediator |
Wojujutari Kenni Ajele, Oyeyemi Bukola Babalola, Egbe Emmanuel Idehen, Teslim Alabi Oladejo |
| 33 |
[GO] |
2022―Mrz―17 |
Experiences from the management of COVID-19 pandemic in a nursing home in Iran (March-April, 2020) |
Shervan Shoaee, Farshid Rezaie, Moloud Payab, Fariborz Bakhtiari, Mohammad-Hossein Heydari |
| 34 |
[GO] |
2022―Mrz―07 |
Diabetes and COVID-19: a bitter nightmare |
Mandana Hasanzad, Bagher Larijani, Hamid Reza Aghaei Meybodi |
| 35 |
[GO] |
2022―Jan―12 |
COVID-19-specific worries among people with type 2 diabetes following the continuation of the pandemic and occurrence of multiple waves of COVID-19 in Iran |
Maryam Peimani, Fatemeh Bandarian, Nazli Namazi, Ensieh Nasli-Esfahani |
| 36 |
[GO] |
2021―Nov―08 |
Association of clinical characteristics, antidiabetic and cardiovascular agents with diabetes mellitus and COVID-19: a 7-month follow-up cohort study |
Marzieh Pazoki, Fatemeh Chichagi, Azar Hadadi, Samira Kafan, Mahnaz Montazeri, Sina Kazemian, Arya Aminorroaya, Mehdi Ebrahimi, Haleh Ashraf, Mojgan Mirabdolhagh Hazaveh, Mohammad Reza Khajavi, Reza Shariat Moharari, Seyed Hamidreza Sharifnia, Shahrokh Karbalai Saleh, Hormat Rahimzadeh, Neda Goodarzi, Peimaneh Heydarian |
| 37 |
[GO] |
2021―Okt―31 |
Spiritual intelligence, mindfulness, emotional dysregulation, depression relationship with mental well-being among persons with diabetes during COVID-19 pandemic |
Wojujutari Kenni Ajele, Teslim Alabi Oladejo, Abimbola A. Akanni, Oyeyemi Bukola Babalola |
| 38 |
[GO] |
2021―Okt―30 |
The effect of underlying diabetes disease on clinical outcome and survival in patients with Covid-19: a propensity score matching study |
Fatemeh Ghadamgahi, Leili Tapak, Saeid Bashirian, Rahimpour Amiri, Ghodratollah Roshanaei |
| 39 |
[GO] |
2021―Okt―28 |
COVID-19 in patients with diabetes: factors associated with worse outcomes |
Negar Rezaei, Fateme Montazeri, Mohammad-Reza Malekpour, Ali Ghanbari, Sina Azadnajafabad, Esmaeil Mohammadi, Nazila Rezaei, Shohreh Naderimagham, Erfan Ghasemi, Mohsen Abbasi-Kangevari, Seyyed-Hadi Ghamari, Maryam Nasserinejad, Farzad Kaveh, Abbas Norouzinejad, Mohammad Mehdi Gouya, Alireza Raeisi, Farshad Farzadfar, Bagher Larijani |
| 40 |
[GO] |
2021―Sep―17 |
New onset of diabetes in a child infected with COVID-19: a case report |
Mahtab Ordooei, Nasrin Behniafard, Fahimeh Soheilipour, Elahe Akbarian |
| 41 |
[GO] |
2021―Sep―14 |
Dissection of non-pharmaceutical interventions implemented by Iran, South Korea, and Turkey in the fight against COVID-19 pandemic |
Mohammad Keykhaei, Sogol Koolaji, Esmaeil Mohammadi, Reyhaneh Kalantar, Sahar Saeedi Moghaddam, Arya Aminorroaya, Shaghayegh Zokaei, Sina Azadnajafabad, Negar Rezaei, Erfan Ghasemi, Nazila Rezaei, Rosa Haghshenas, Yosef Farzi, Sina Rashedi, Bagher Larijani, Farshad Farzadfar |
| 42 |
[GO] |
2021―Aug―27 |
The impact of COVID-19 pandemic on glycemic control in patients with diabetes mellitus in Turkey: a multi-center study from Kocaeli |
Alev Selek, Emre Gezer, Eda Altun, Mehmet Sözen, Ömercan Topaloğlu, Damla Köksalan, Halil Demirkan, Dilek Karakaya, Berrin Cetinarslan, Zeynep Cantürk, Dilek Taymez |
| 43 |
[GO] |
2021―Jul―14 |
Impacts of diabetes mellitus on clinical and para-clinical parameters among COVID-19 patients |
AliReza Estedlal, Marjan Jeddi, Seyed Taghi Heydari, Mehdi Ghaderian Jahromi, Mohammad Hossein Dabbaghmanesh |
| 44 |
[GO] |
2021―Jun―26 |
Treatment with a DPP-4 inhibitor at time of hospital admission for COVID-19 is not associated with improved clinical outcomes: data from the COVID-PREDICT cohort study in The Netherlands |
Rick I. Meijer, Trynke Hoekstra, Niels C. Gritters van den Oever, Suat Simsek, Joop P. van den Bergh, Renée A. Douma, Auke C. Reidinga, Hazra S. Moeniralam, Tom Dormans, Mark M. Smits |
| 45 |
[GO] |
2021―Jun―26 |
Association between cardiometabolic risk factors and COVID-19 susceptibility, severity and mortality: a review |
Yasaman Sharifi, Moloud Payab, Erfan Mohammadi-Vajari, Seyed Morsal Mosallami Aghili, Farshad Sharifi, Neda Mehrdad, Elham Kashani, Zhaleh Shadman, Bagher Larijani, Mahbube Ebrahimpur |
| 46 |
[GO] |
2021―Apr―05 |
Nutritional management of diabetes mellitus during the pandemic of COVID-19: a comprehensive narrative review |
Sepideh Mahluji, Mahsa Jalili, Alireza Ostadrahimi, Jamal Hallajzadeh, Vahideh Ebrahimzadeh-Attari, Maryam Saghafi-Asl |
| 47 |
[GO] |
2021―Mrz―31 |
Diabetes prevalence and mortality in COVID-19 patients: a systematic review, meta-analysis, and meta-regression |
Sumanta Saha, Rami H. Al-Rifai, Sujata Saha |
| 48 |
[GO] |
2021―Mrz―29 |
Vitamin D and COVID-19: is there a role? |
Aysha Habib Khan, Noreen Nasir, Nosheen Nasir, Quratulain Maha, Rehana Rehman |
| 49 |
[GO] |
2021―Mrz―27 |
Dipeptidyl peptidase 4 (DPP4) inhibitor and outcome from coronavirus disease 2019 (COVID-19) in diabetic patients: a systematic review, meta-analysis, and meta-regression |
Timotius Ivan Hariyanto, Andree Kurniawan |
| 50 |
[GO] |
2021―Feb―26 |
Proportion and mortality of Iranian diabetes mellitus, chronic kidney disease, hypertension and cardiovascular disease patients with COVID-19: a meta-analysis |
Hamid Mirjalili, Seyed Alireza Dastgheib, Seyed Hossein Shaker, Reza Bahrami, Mahta Mazaheri, Seyed Mohamad Hossein Sadr-Bafghi, Jalal Sadeghizadeh-Yazdi, Hossein Neamatzadeh |
| 51 |
[GO] |
2021―Jan―29 |
Scientometric analyzing the output of researchers and organizations on COVID-19 for better conducting the scientific efforts: with a glance to endocrinology |
Rasha Atlasi, Abdolreza Noroozi Chakoli, Aboozar Ramezani, Ozra Tabatabaei-Malazy, Bagher Larijani |
| 52 |
[GO] |
2021―Jan―07 |
Risk indicators associated with in-hospital mortality and severity in patients with diabetes mellitus and confirmed or clinically suspected COVID-19 |
Marzieh Pazoki, Mohammad Keykhaei, Samira Kafan, Mahnaz Montazeri, Mojgan Mirabdolhagh Hazaveh, Mehran Sotoodehnia, Sina Kazemian, Mohammad Talebpour, Haleh Ashraf, Reza Shariat Moharari, Fazeleh Majidi, Nazanin Hedayati Amlashi, Sara Zare, Maryam Fathi, Zohre Azimbeik, Mehdi Ebrahimi |
| 53 |
[GO] |
2021―Jan―03 |
Smartphones for gestational diabetes in the COVID-19 era |
Ioannis Ilias |
| 54 |
[GO] |
2020―Nov―23 |
Non-communicable Diseases and COVID-19; a double-edged sword A Special Communication from IRAN |
Niloofar Peykari, Sana Eybpoosh, Hamidreza Safikhani, Ali Akbar Haghdoost, Ozra Tabatabaei-Malazy, Bagher Larijani |
| 55 |
[GO] |
2020―Nov―06 |
COVID-19: a one-way ticket to a global childhood obesity crisis? |
Sarah Cuschieri, Stephan Grech |
| 56 |
[GO] |
2020―Okt―29 |
Prevalence and severity of depression, anxiety, stress and perceived stress in hospitalized patients with COVID-19 |
Atefeh Zandifar, Rahim Badrfam, Shahrooz Yazdani, Seyed Masoud Arzaghi, Fatemeh Rahimi, Somayeh Ghasemi, Somayeh Khamisabadi, Nami Mohammadian Khonsari, Mostafa Qorbani |
| 57 |
[GO] |
2020―Okt―26 |
The mental health of healthcare workers in the COVID-19 pandemic: A systematic review |
Maryam Vizheh, Mostafa Qorbani, Seyed Masoud Arzaghi, Salut Muhidin, Zohreh Javanmard, Marzieh Esmaeili |
| 58 |
[GO] |
2020―Okt―20 |
Biological response modifier glucan through balancing of blood glucose may have a prophylactic potential in COVID-19 patients |
Nobunao Ikewaki, Masaru Iwasaki, Samuel J. K. Abraham |
| 59 |
[GO] |
2020―Okt―19 |
The burden of type 2 diabetes pre-and during the COVID-19 pandemic - a review |
Justine Sciberras, Lara Maria Camilleri, Sarah Cuschieri |
| 60 |
[GO] |
2020―Okt―17 |
Macrophages in diabetes mellitus (DM) and COVID-19: do they trigger DM? |
Małgorzata Kloc, Rafik M. Ghobrial, Sławomir Lewicki, Jacek Z. Kubiak |
| 61 |
[GO] |
2020―Okt―09 |
Factors associated with the poor outcomes in diabetic patients with COVID-19 |
Hadith Rastad, Hanieh-Sadat Ejtahed, Armita Mahdavi-Ghorabi, Masoud Arzaghi, Anis Safari, Ehsan Shahrestanaki, Mohammad Rezaei, Mohammad Mahdi Niksima, Akram Zakani, Seyede Hanieh Dehghan Manshadi, Fatemeh Ochi, Shabnam Saedi, Zeinab Khodaparast, Neda Shafiabadi Hassani, Mehdi Azimzadeh, Mostafa Qorbani |
| 62 |
[GO] |
2020―Aug―14 |
Contribution of Iran in COVID-19 studies: a bibliometrics analysis |
Amrollah Shamsi, Mohammad Javad Mansourzadeh, Arash Ghazbani, Kazem Khalagi, Noushin Fahimfar, Afshin Ostovar |
| 63 |
[GO] |
2020―Jul―20 |
A brief analysis and hypotheses about the risk of COVID-19 for people with type 1 and type 2 diabetes mellitus |
Charalampos Milionis, Stella Olga Milioni |
| 64 |
[GO] |
2020―Jul―02 |
The most important challenges ahead of microbiome pattern in the post era of the COVID-19 pandemic |
Hanieh-Sadat Ejtahed, Shirin Hasani-Ranjbar, Seyed Davar Siadat, Bagher Larijani |
| 65 |
[GO] |
2020―Jun―09 |
Telehealth for fighting the novel coronavirus: review of activities on Diabetes and Osteoporosis management in outbreak |
Mahnaz Sanjari, Maryam Aalaa, Afshin Ostovar, Ensieh Nasli Esfehani, Bagher Larijani |
| 66 |
[GO] |
2020―Mai―30 |
Drug repurposing using computational methods to identify therapeutic options for COVID-19 |
Soodeh Mahdian, Azadeh Ebrahim-Habibi, Mahboobeh Zarrabi |
| 67 |
[GO] |
2020―Apr―30 |
Ramadan fasting during Covid-19 pandemic |
Ali Tootee, Bagher Larijani |
